1) Diabetic osteoporosis
糖尿病性骨质疏松症
1.
To study the characteristics of clinical syndromes in diabetic osteoporosis and its early diagnostic and therapeutic methods.
为了解糖尿病性骨质疏松症患者的临床证候特点 ,探讨其早期诊断思路与治法 ,对 42例患者进行临床症状、体征调查及证候辨证 ,结果显示肾虚髓亏、脾气不足、血行不畅在所有患者中均存在 ,为糖尿病性骨质疏松症的主证 ,提示该病的治则应以益肾、健脾、补髓、壮骨、活血相结合 ,临床可以根据其主证及常见症状作出早期诊
2.
To study the clinical effects of QIANGGUBAO(QGB) on diabetic osteoporosis(DOP),the changes of clinical symptoms and bone density in 40 cases before and after being treated with DOP were observed.
为了解强骨宝对糖尿病性骨质疏松症 ( DOP)的临床疗效 ,对 4 0例 DOP患者进行强骨宝颗粒剂用药前后临床症状、骨密度等指标变化的观察。
2) Diabetes osteoporosis
糖尿病骨质疏松症
1.
Diabetes osteoporosis is a complex disease which will constantly happen in diabetes patients.
糖尿病骨质疏松症作为糖尿病的常见复合性疾病,以其发病率、致残率高而成为世界医学界研究的热点。
3) diabetic osteoporosis
糖尿病性骨质疏松
1.
Recently, many studies show that the incidence of diabetic osteoporosis(DO) was much higher than other chronic complications of diabetes.
近些年的研究表明，糖尿病性骨质疏松发病率远远高于其它并发症，引起全身性骨痛，易发生骨折，致残致死率高，已引起医学专家和临床工作者的广泛重视。
2.
Objective:To investigate the regulating action and its mechanism of Bushenzhuanggu Capsule(BC) on bone resorption-formation discoupling in Diabetic Osteoporosis(DO) rats models induced by Alloxan(ALX) intraperitoneally.
目的：探讨补肾壮骨胶囊对糖尿病性骨质疏松(DO)模型大鼠骨吸收—形成解耦联的调节作用及其机制。
4) Diabetic osteoporosis
糖尿病骨质疏松
1.
Objective:To observe the effects of glucose on the differentiation of osteoclast derived from rat bone marrow cells,and to study the role of glucose in pathogenesis of diabetic osteoporosis.
目的观察葡萄糖对大鼠骨髓破骨细胞(OC)分化的影响,探讨糖尿病骨质疏松的发病机制。
5) type 2 diabetes with osteoporos
糖尿病骨质疏松
1.
Objective:To observe the effect of Tanggukang on bone density(BMD),fasting blood glucose(FBG), glycosylated hemoglobin,the bone gla protein(BGP)in serum of patients of type 2 diabetes with osteoporos.
目的:观察糖骨康对糖尿病骨质疏松患者骨密度(BMD)、空腹血糖(FBG)、糖化血红蛋白和血清骨钙素(BGP)含量的影响。
2.
Objectior:To observe the effect of Tanggukang on bone density(BMD),fasting blood glucose(FBG),glycosylated hemoglobin(HbA1c),the content of bone gla protein(BGP),bone alkaline phosphatase(BALP),insulin-like growth factor 1(IGF-1) in the serum and calcium(Ca),phosphours(P),Urine protein(PRO)in urine of patients of type 2 diabetes with osteoporos.
目的:观察糖骨康对糖尿病骨质疏松患者骨密度(BMD)、空腹血糖(FBG)、糖化血红蛋白(HbA1 c)和血清骨钙素(BGP)、骨碱性磷酸酶(BALP)、胰岛素样生长因子-1(IGF-1)以及24h尿蛋白(PRO)、尿钙(Ca)、尿磷(P)含量的影响。
6) male osteoporosis
男性骨质疏松症
1.
The practice of health education in male osteoporosis using nursing process;
应用护理程序开展男性骨质疏松症健康教育实践
2.
Correlative Research between Male Osteoporosis and Nitrogen Monoxide;
男性骨质疏松症与一氧化氮相关性研究
3.
Male osteoporosis is often overlooked,but male osteoporotic fracture induce more mortality than female osteoporotic fracture,and diagnosis for male osteoporosis has some problems on T scope and value of BMD.
男性骨质疏松症常被忽视,但男性骨质疏松性骨折的死亡率比女性高,且男性诊断骨质疏松症的T值和BMD范围等还存在不同意见。
补充资料：老年性骨质疏松症
老年性骨质疏松症
老年性骨质疏松症又称为Ⅰ型骨质疏松症，发生的年龄为70岁以上，男女性发生比率为1∶2，骨丢失的类型为松质骨和密质骨，处于低骨转换状态，骨丢失速率较缓慢，无骨加速丢失现象，骨折发生部位为椎体(多个楔形)及股骨。老年性骨质疏松发生的原因和年龄老化有关，表现为钙吸收减少，甲状旁腺功能亢进，25-(OH)-D转变为1，25-(OH)2-D3的代谢减低。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条